| http://www.w3.org/ns/prov#value | - mically disadvantaged groups.For the treatment of MDR-TB, the addition of pyrazinamide to a minimum of four second-line anti-TB drugs likely to be effective is recommended, including the use of second-line injectable drugs, as well as the use of fluoroquinolones (earlier generations of fluoroquinolones, ciprofloxacin and ofloxacin, are no longer recommended when later generation fluoroquinolones
|
